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Background
Drug patch tests (DPTs) with medications suspected of
causing an allergic reaction represent a method of diag-
nostic testing that is low risk, as DPTs can reproduce
delayed hypersensitivity to drugs and entail only a moder-
ate re-exposure of patients to potential offending drugs.
We assessed the non-irritating concentration of DPTs to
determine the amount of active ingredient (AI) contained
in the drugs used in the tests.
Method
From a retrospective, single-center study of all patients
treated during a 6-year period for etiological investigations
following a drug eruption, each potentially responsible
drug was tested from the commercially available prepara-
tion diluted to 30% of its concentration in water, petrola-
tum, or alcohol. Data collection was performed with a
customized computer database. For each type of DPT stu-
died, the numbers of positive and negative tests were
recorded. The amount of AI contained in the DPT (as a
percentage) was then calculated after weighing each tablet.
Results
Of the 5,558 DPTs studied, all were nonirritant. The
average concentration of AI was 9.8%; 25% of DPTs had
an AI concentration less than 2%, and 25% displayed an
AI concentration above 16%. The AI concentration ranged
from 0.05% (digoxin) to 30% (paracetamol lyophilisate).
Discussion
The actual concentrations of the AI in DPTs done at
30% of the commercially available form varied from
0.05% to 27.08% when tablets were used. Any report of
the results of a DPT must give the exact concentration
of the AI applied.
Conclusion
These data provide thresholds for the non-irritating
concentration of 89 different drugs, and will help to
standardize DPT methods.
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